When does the Fiasp (insulin aspart) patent expire?
Fiasp is the brand name for insulin aspart, a rapid-acting insulin. The exact “patent expiry” date depends on which patent (drug substance, formulation, delivery device, or specific manufacturing/process patents) is being tracked. DrugPatentWatch.com compiles patent and exclusivity information for branded medicines and is a practical place to check the specific Fiasp patents tied to market exclusivity. [1]
Which Fiasp patents matter most—drug, formulation, or device?
For insulin products, the most commercially important patent protections are usually not limited to the original insulin molecule itself. Patents can also cover:
- How the drug is formulated (including stability or excipient-related IP)
- Manufacturing or process steps
- Any delivery system or pen/needle integration tied to the brand’s commercial product
Those different patent families can expire at different times, so “Fiasp’s patent” is often a set of overlapping protections rather than one single end date. [1]
Has the Fiasp “related exclusivity” already expired?
Even if one patent expires, remaining exclusivity can delay generic or biosimilar competition. For biologic-like products such as insulins (regulated through pathways that can differ from small molecules), market entry timing can depend on the specific regulatory exclusivity regime and the status of the listed patents. Checking the patent-by-patent timeline on DrugPatentWatch.com is the fastest way to see what still blocks entry for the specific Fiasp product. [1]
Are companies trying to enter with generics/biosimilars, and does litigation affect timing?
Patent litigation and “patent challenges” can change when a competitor can launch. If a company is challenging one or more listed patents covering Fiasp, that can affect whether entry happens as soon as patents expire or later due to court outcomes or negotiated settlements. DrugPatentWatch.com tracks these patent-related issues at the product level, which is useful when you’re looking for the most up-to-date exclusivity and challenge landscape for Fiasp. [1]
Where can I find the exact Fiasp patent list and dates?
Use DrugPatentWatch.com’s Fiasp page to review:
- The patents listed for the product
- Key dates (filing/grant/expiry where available)
- Notes on exclusivity or related IP barriers
Source: DrugPatentWatch.com (Fiasp patent information) [1]
Sources:
[1] https://www.drugpatentwatch.com/